A new weight loss drug that has been hailed as the latest treatment to fight obesity in England, is to be evaluated by health authorities in New Zealand.


The pill, Acomplia, made by the French pharmaceutical firm Sanofi-Aventis, is thought to help curb a person's appetite and to help reduce the risk of diabetes and heart disease.


Dubbed 'the wonder pill', studies have found that it cuts body weight by up to 10 percent within one year.

Available through a prescription in the UK, now the drug is to be marketed in New Zealand.
The drug is currently under evaluation by health officials in New Zealand.


According to the New Zealand Herald, the drug has been hailed as a breakthrough in treating obesity by some in the medical fraternity overseas on the basis of interim study results.



Source: All Headline News